BillionToOne, Inc. BLLN Clinical trial support and other services — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BillionToOne, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BillionToOne, Inc. 's clinical trial support and other services — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BillionToOne, Inc. 's clinical trial support and other services — revenue?
- BillionToOne, Inc. (BLLN) reported clinical trial support and other services — revenue of $1.14M in Q1 2026.
- How has BillionToOne, Inc. 's clinical trial support and other services — revenue changed year-over-year?
- BillionToOne, Inc. 's clinical trial support and other services — revenue increased by 61.0% year-over-year, from $710K to $1.14M.
- What does clinical trial support and other services — revenue mean?
- This metric represents the total revenue generated from providing specialized support services to clinical trials and other ancillary diagnostic service offerings. It reflects the company's ability to monetize its molecular counting platform and diagnostic expertise through partnerships with pharmaceutical or research organizations. This revenue stream serves as an indicator of the company's diversification beyond core diagnostic product sales and its integration into the broader clinical research ecosystem.